camptothecin has been researched along with Diffuse Parenchymal Lung Disease in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (16.67) | 29.6817 |
| 2010's | 14 (46.67) | 24.3611 |
| 2020's | 11 (36.67) | 2.80 |
| Authors | Studies |
|---|---|
| Acharyya, S; Bazhenova, L; Cheng, Y; Felip, E; Goto, Y; Jänne, PA; Li, BT; Mazières, J; Nagasaka, M; Nakagawa, K; Pacheco, JM; Paz-Ares, L; Pérol, M; Planchard, D; Saltos, AN; Saxena, K; Shahidi, J; Shiga, R; Smit, EF; Udagawa, H; Vitazka, P | 1 |
| Bako, E; Cathcart, J; Chiu, JWY; Chung, CF; Chung, WP; Cortés, J; Curigliano, G; Hamilton, E; Hegg, R; Huang, CS; Hurvitz, SA; Im, SA; Iwata, H; Kim, JH; Kim, MH; Kim, SB; Lee, C; Liu, Y; Park, YH; Pedrini, JL; Petry, V; Tseng, LM; Verma, S; Xu, B | 1 |
| Andre, F; Bartholmai, BJ; Conte, P; Kato, T; Lancaster, LH; Li, BT; Naidoo, J; Nicholson, AG; Nishino, M; Powell, CA; Schumacher-Wulf, E; Shitara, K; Swain, SM; Tsurutani, J | 1 |
| Abuhelwa, Z; Alloghbi, A; Alqahtani, A; Nagasaka, M | 1 |
| Camidge, DR; Chang, DY; Iwata, H; Macpherson, E; Modi, S; Powell, CA; Qin, A; Shire, N; Siena, S; Singh, J; Smit, EF; Taitt, C; Takahashi, S | 1 |
| Bianchini, G; Cortes, J; Henning, JW; Rugo, HS; Untch, M | 1 |
| Andre, F; Aogi, K; Chen, S; Cortes, J; Denduluri, N; Hurvitz, SA; Im, SA; Ito, Y; Iwata, H; Kim, SB; Krop, I; Lee, C; Lee, KS; Modi, S; Park, YH; Perrin, C; Saura, C; Shahidi, J; Sohn, J; Tamura, K; Tokunaga, E; Tsurutani, J; Yamashita, T; Yver, A; Zhang, L | 1 |
| Bang, YJ; Chung, HC; Iwasa, S; Kamio, T; Kawaguchi, Y; Kawakami, H; Kojima, A; Lee, J; Ryu, MH; Saito, K; Sakai, D; Shitara, K; Sugihara, M; Sugimoto, N; Yabusaki, H; Yamaguchi, K | 1 |
| Camidge, DR; Danysh, HE; Hackshaw, MD; Iwata, H; Ladner, A; Powell, CA; Ritchey, ME; Singh, J; Taitt, C | 1 |
| Aida, T; Kai, K; Kishino, Y; Kumagai, K; Mori, K; Tsuchiya, Y | 1 |
| Baba, E; Fujii, S; Fujitani, K; Oki, E; Shitara, K; Yamaguchi, K | 1 |
| Aizawa, K; Furukawa, T; Kozakai, H; Mitsuboshi, S; Nagai, K; Yamada, H | 1 |
| Aoyagi, H; Higuchi, K; Ito, H; Ito, M; Koseki, K; Nihei, Z; Nishi, N; Suzuki, K; Tanaka, Y; Watanabe, I | 1 |
| Akahori, D; Amano, T; Hasegawa, H; Kakutani, T; Koda, K; Kunimoto, Y; Matsui, T; Niwa, H; Ozawa, Y; Suda, T; Tanahashi, M; Yamada, K; Yokomura, K | 1 |
| Ahmed, A; Kozma, K; Patel, S; Rezkallah, KNM | 1 |
| Akashi, K; Ariyama, H; Baba, E; Ijichi, K; Komoda, M; Kubo, N; Kusaba, H; Tamura, S; Tsuchihashi, K; Uchino, K | 1 |
| Hama, N; Haraguchi, N; Hirao, M; Ikeda, M; Maeda, S; Miyake, M; Miyamoto, A; Miyazaki, M; Nakamori, S; Nishikawa, K; Sekimoto, M; Takeda, T; Uemura, M; Yamamoto, K | 1 |
| Aoki, Y; Furuta, R; Hibi, S; Ina, K; Kabeya, M; Kataoka, T; Kawai, M; Kayukawa, S; Kojima, S; Masaki, A; Mori, F; Nagao, S; Yamada, K | 1 |
| Baba, N; Ishigami, S; Kitaguchi, K; Nakauchi, M; Nakayama, Y; Ohe, H; Sakikubo, M; Taira, K; Tamura, J; Ura, K; Yoshikawa, A | 1 |
| Doi, T; Fuse, N; Joh, T; Minashi, K; Ohtsu, A; Shimura, T; Tahara, M; Yoshino, T | 1 |
| Fukuoka, M; Komiya, T; Kurata, T; Miyazaki, M; Nakagawa, K; Takeda, K; Tamura, K; Tsurutani, J; Yamamoto, N | 1 |
| Ikeda, H; Ito, T; Kawamoto, K; Ogasahara, K; Yokota, M | 1 |
| Furushima, K; Ishihara, T; Katou, Y; Tanai, C; Tanaka, Y; Usui, K | 1 |
| Arita, M; Fujino, H; Kuga, Y; Miwata, T; Moriya, T; Ohya, T; Okanobu, H; Tanaka, T; Yoshimi, S | 1 |
| Gemma, A; Kakihata, K; Kon, A; Nagashima, M; Suzuki, T; Yoshii, N | 1 |
| Aoyagi, H; Hamada, S; Hasegawa, K; Kaneko, J; Katsuta, E; Maejima, S; Saguchi, M; Someno, Y; Takahata, T; Yoshida, T | 1 |
| Abe, T; Ando, M; Kato, T; Nakashima, H; Shindo, J; Shiraki, A; Yamamoto, K; Yukita, Y | 1 |
| Lobrinus, JA; Matzinger, O; Michielin, O; Périard, D; Stupp, R; Udry, E | 1 |
| Sandler, AB | 1 |
| Bjarnason, GA; Madarnas, Y; Shorter, AM; Webster, P | 1 |
8 review(s) available for camptothecin and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management.
Topics: Camptothecin; Humans; Immunoconjugates; Lung Diseases, Interstitial; Pneumonia; Trastuzumab | 2022 |
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review.
Topics: Adult; Camptothecin; Carcinoma, Non-Small-Cell Lung; Humans; Immunoconjugates; Lung Diseases, Interstitial; Lung Neoplasms; Pneumonia; Receptor, ErbB-2; Trastuzumab | 2022 |
Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer.
Topics: Alopecia; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Camptothecin; Fatigue; Female; Humans; Immunoconjugates; Lung Diseases, Interstitial; Nausea; Neutropenia; Trastuzumab; Ventricular Dysfunction, Left; Vomiting | 2022 |
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer.
Topics: Ado-Trastuzumab Emtansine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Disease Management; Drug Monitoring; Everolimus; Female; Humans; Immunoconjugates; Incidence; Lapatinib; Lung Diseases, Interstitial; Neoplasm Metastasis; Paclitaxel; Pneumonia; Receptor, ErbB-2; Trastuzumab | 2020 |
Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer.
Topics: Camptothecin; Drug Development; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Immunoconjugates; Lung Diseases, Interstitial; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab | 2021 |
[A Case of Rectal Cancer Completely Resected after Successful Treatment with Irinotecan plus Cetuximab-Induced Interstitial Pneumonia with Steroid Pulse Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Combined Modality Therapy; Humans; Irinotecan; Lung Diseases, Interstitial; Male; Rectal Neoplasms; Saponins | 2015 |
[A case of irinotecan or panitumumab-induced interstitial pneumonia successfully treated by steroid pulse therapy].
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Organoplatinum Compounds; Panitumumab; Tomography, X-Ray Computed | 2012 |
Nondermatologic adverse events associated with anti-EGFR therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cetuximab; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Humans; Irinotecan; Lung Diseases, Interstitial; Lung Neoplasms; Protein-Tyrosine Kinases; Quinazolines | 2006 |
5 trial(s) available for camptothecin and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Trastuzumab Deruxtecan in
Topics: Adult; Aged; Aged, 80 and over; Camptothecin; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up Studies; Humans; Immunoconjugates; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Pneumonia; Progression-Free Survival; Receptor, ErbB-2; Trastuzumab | 2022 |
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Topics: Ado-Trastuzumab Emtansine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Breast Neoplasms; Camptothecin; Female; Humans; Immunoconjugates; Kaplan-Meier Estimate; Lung Diseases, Interstitial; Middle Aged; Pneumonia; Progression-Free Survival; Receptor, ErbB-2; Trastuzumab | 2022 |
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Consolidation Chemotherapy; Female; Humans; Immunoconjugates; Intention to Treat Analysis; Kaplan-Meier Estimate; Lung Diseases, Interstitial; Middle Aged; Progression-Free Survival; Receptor, ErbB-2; Trastuzumab | 2020 |
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Marrow; Camptothecin; Esophageal Neoplasms; Female; Humans; Immunoconjugates; Irinotecan; Lung Diseases, Interstitial; Male; Middle Aged; Paclitaxel; Receptor, ErbB-2; Stomach Neoplasms; Survival Analysis; Trastuzumab | 2020 |
A phase I study of gemcitabine plus irinotecan for advanced NSCLC: Japan Clinical Oncology Group Trial (JCOG9904).
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asian People; Camptothecin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Irinotecan; Japan; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Treatment Outcome | 2010 |
17 other study(ies) available for camptothecin and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies.
Topics: Aged; Camptothecin; Humans; Immunoconjugates; Lung Diseases, Interstitial; Pneumonia; Retrospective Studies; Trastuzumab | 2022 |
Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2-targeting Ab-drug conjugate, in monkeys.
Topics: Animals; Camptothecin; Cathepsin B; Drug Administration Schedule; Female; Immunoconjugates; Lung; Lung Diseases, Interstitial; Macaca fascicularis; Male; Receptor, ErbB-2; Time Factors; Trastuzumab | 2020 |
Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Lung Diseases, Interstitial; Male; Neutropenia; Organoplatinum Compounds; Tomography, X-Ray Computed | 2018 |
[A Case of Fatal Interstitial Pneumonia during FOLFIRI plus Cetuximab Therapy for Liver Metastasis of Colon Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Fatal Outcome; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Diseases, Interstitial; Sigmoid Neoplasms | 2018 |
Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Camptothecin; Female; Follow-Up Studies; Humans; Irinotecan; Lung Diseases, Interstitial; Lung Injury; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors | 2018 |
A case of panitumumab containing chemotherapy causing interstitial lung disease: early recognition and treatment resulting in a good outcome.
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Early Diagnosis; Early Medical Intervention; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Diseases, Interstitial; Male; Panitumumab; Radiography, Thoracic; Tomography, X-Ray Computed | 2019 |
Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lung Diseases, Interstitial; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prednisolone; Prognosis; Radiography, Thoracic; Retrospective Studies | 2014 |
[A case of interstitial pneumonia induced by S-1/irinotecan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinations; Humans; Irinotecan; Liver Neoplasms; Lung Diseases, Interstitial; Male; Oxonic Acid; Tegafur; Tomography, X-Ray Computed; Treatment Failure | 2008 |
[A case of interstitial pneumonitis induced by FOLFIRI+bevacizumab combination therapy for liver and lung metastasis of colon cancer].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Middle Aged; Sigmoid Neoplasms | 2009 |
Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Lung Diseases, Interstitial; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
[A case of irinotecan-induced interstitial pneumonia during treatment of recurrent colon cancer].
Topics: Aged; Camptothecin; Fatal Outcome; Humans; Irinotecan; Lung Diseases, Interstitial; Male; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2010 |
Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alveolitis, Extrinsic Allergic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Japan; Leucovorin; Lung Diseases, Interstitial; Male; Medical Records Systems, Computerized; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Pulmonary Fibrosis; Retrospective Studies; Severity of Illness Index; Smoking; Tomography, X-Ray Computed | 2011 |
[A case of drug-induced interstitial pneumonia caused by S-1 and CPT-11 combination therapy for advanced colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinations; Fatal Outcome; Female; Humans; Irinotecan; Lung Diseases, Interstitial; Neoplasm Staging; Oxonic Acid; Tegafur; Tomography, X-Ray Computed | 2011 |
Clarification of clinical features of interstitial lung disease induced by irinotecan based on postmarketing surveillance data and spontaneous reports.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Hypersensitivity; Female; Humans; Irinotecan; Lung Diseases, Interstitial; Male; Middle Aged; Neoplasms; Pneumonia; Product Surveillance, Postmarketing; Pulmonary Alveoli; Steroids; Tomography, X-Ray Computed | 2011 |
[A case of interstitial pneumonia induced by CPT-11 for local recurrence of rectal cancer].
Topics: Camptothecin; Combined Modality Therapy; Fatal Outcome; Humans; Irinotecan; Lung Diseases, Interstitial; Male; Middle Aged; Rectal Neoplasms; Recurrence | 2011 |
Irinotecan-induced interstitial pneumonia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Dacarbazine; Diagnosis, Differential; Frontal Lobe; Glioblastoma; Humans; Irinotecan; Lung Diseases, Interstitial; Male; Radiography; Temozolomide | 2004 |
Irinotecan-associated pulmonary toxicity.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Colorectal Neoplasms; Humans; Irinotecan; Lung Diseases, Interstitial; Male; Middle Aged | 2000 |